Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments improved hair loss, but 15% Minoxidil caused more side effects than Low Level Laser Therapy.

Liposomes improve finasteride delivery for hair loss treatment, making it a promising option for topical use.

A new method using nanolipogels with fucosterol can help regrow hair by targeting follicles, reducing inflammation, and improving blood flow.

Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.

The new 5% minoxidil formulation without propylene glycol effectively promotes hair growth with fewer side effects and better user satisfaction.

PRP therapy improves hair density and satisfaction more than Minoxidil for androgenetic alopecia.

Liposomes could improve how skin care products work but are costly and not very stable.

Topical finasteride is as effective and safe as minoxidil for treating female pattern hair loss.

15d‐PGJ2 cream protects against UVB-induced skin damage in mice.

The microneedle system effectively promotes hair growth for treating androgenic alopecia.

Using finasteride and minoxidil together improves the frontal hairline best in male hair loss.

Croton tiglium application significantly improved hair regrowth in alopecia areata patients.

Both treatments help hair regrowth, with PRP being slightly better.

New treatments using stem cells and special materials show promise for severe eye surface disease.

0.05% betamethasone dipropionate is the most effective treatment for mild alopecia areata.

The minoxidil and finasteride foam remains stable and effective for 180 days at room temperature.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Smaller, diluted corticosteroid injections reduce the risk of vision loss.

Both treatments for localized alopecia areata are equally effective.

Combining β-sitosterol nanoparticles with laser therapy may effectively stimulate hair growth in androgenetic alopecia.

Topical spironolactone and minoxidil both effectively treat female hair loss, but spironolactone has fewer side effects.

Combined light therapy improves eye health and quality of life for those with meibomian gland dysfunction.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Topical finasteride can effectively treat male pattern baldness with fewer side effects than oral use.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Brimonidine is effective for reducing facial redness in skin conditions and has potential for broader dermatological uses.

A new treatment using special microneedles and a nitric oxide-releasing drug could improve hair growth and be more convenient for people with hair loss.